GLO1 and diabetic foot: For instance, it has been shown the therapeutic potential of a biocompatible scaffold incorporating genes for both GLO-1 and β-klotho to reduce MG levels and reprogram diabetic adipose-derived stem cells (dADSCs) for the treatment of diabetic foot ulcers (31).